| scholarly article | Q13442814 |
| P50 | author | Su Ih-jen | Q90847857 |
| P2093 | author name string | Yi-Chun Chen | |
| Ching-Chuan Liu | |||
| Chun-Keung Yu | |||
| Ya-Fang Wang | |||
| Ih-Jen Su | |||
| Huan-Yao Lei | |||
| P433 | issue | Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 69-77 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | A murine oral enterovirus 71 infection model with central nervous system involvement | |
| P478 | volume | 85 |
| Q35905668 | A Consistent Orally-Infected Hamster Model for Enterovirus A71 Encephalomyelitis Demonstrates Squamous Lesions in the Paws, Skin and Oral Cavity Reminiscent of Hand-Foot-and-Mouth Disease |
| Q27334321 | A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema |
| Q43273718 | A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro |
| Q35702513 | A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection |
| Q59336456 | A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5 |
| Q35826494 | A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection |
| Q96816277 | A novel orally infected hamster model for Coxsackievirus A16 hand-foot-and-mouth disease and encephalomyelitis |
| Q48051435 | A reverse genetic study of the adaptation of human enterovirus 71 to growth in Chinese hamster ovary cell cultures |
| Q41595788 | A simple and highly repeatable viral plaque assay for enterovirus 71. |
| Q34635242 | Adaptation of enterovirus 71 to adult interferon deficient mice |
| Q92223179 | An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates |
| Q35740892 | An enterovirus 71 strain causes skeletal muscle damage in infected mice |
| Q58098748 | An update on enterovirus 71 infection and interferon type I response |
| Q33579809 | Animal models of enterovirus 71 infection: applications and limitations |
| Q39282870 | Antiviral protection against enterovirus 71 mediated by autophagy induction following FLICE-inhibitory protein inactivation |
| Q33602804 | Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice |
| Q37028755 | Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study |
| Q36965378 | Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29. |
| Q57042567 | Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition) |
| Q35192859 | Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. |
| Q92457870 | Construction and characterization of an infectious cDNA clone of coxsackievirus A 10 |
| Q36483299 | Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model |
| Q34177586 | Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice. |
| Q46376571 | Diverse apoptotic pathways in enterovirus 71-infected cells |
| Q28606867 | Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice |
| Q33729001 | Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling |
| Q28072189 | Enterovirus 71 infection and neurological complications |
| Q40509621 | Enterovirus 71 infection caused neuronal cell death and cytokine expression in cultured rat neural cells |
| Q37416863 | Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway |
| Q41708968 | Enterovirus 71 infects brain-derived neural progenitor cells |
| Q92322306 | Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model |
| Q35112613 | Enterovirus 71 virion-associated galectin-1 facilitates viral replication and stability |
| Q39846187 | Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication |
| Q34544363 | Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model |
| Q40200579 | Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. |
| Q34532705 | Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model |
| Q43291847 | Enterovirus 71: epidemiology, pathogenesis and management |
| Q54260296 | Enterovirus A71 Proteins: Structure and Function. |
| Q92218941 | Enteroviruses: A Gut-Wrenching Game of Entry, Detection, and Evasion |
| Q59356338 | Establishment and characterization of an oral gerbil model for a non-mouse-adapted enterovirus 71 strain |
| Q81196924 | Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection |
| Q52662212 | Factors associated with fatal outcome of children with enterovirus A71 infection: a case series. |
| Q24337770 | Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy |
| Q42214658 | Histopathological features and distribution of EV71 antigens and SCARB2 in human fatal cases and a mouse model of enterovirus 71 infection |
| Q34603659 | Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. |
| Q24815070 | Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection |
| Q59349670 | Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy |
| Q34593800 | Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71 |
| Q47145137 | Immunopathogenesis and Virus-Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease |
| Q46801574 | Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys |
| Q39412134 | In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection |
| Q45401009 | Inhibition of enterovirus 71 in virus-infected mice by RNA interference. |
| Q45891110 | MRI findings of neurological complications in hand-foot-mouth disease by enterovirus 71 infection |
| Q33906139 | Machine Learning Algorithms for Risk Prediction of Severe Hand-Foot-Mouth Disease in Children |
| Q40126540 | Modelling person-to-person transmission in an Enterovirus A71 orally infected hamster model of hand-foot-and-mouth disease and encephalomyelitis |
| Q39350594 | Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. |
| Q96586665 | Muscle destruction caused by coxsackievirus A10 in gerbils: construction of a novel animal model for antiviral evaluation |
| Q37008702 | Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection |
| Q83286490 | Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection |
| Q30491567 | Neuro-Magnetic Resonance Imaging in Hand, Foot, and Mouth Disease: Finding in 412 Patients and Prognostic Features |
| Q35909516 | Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models. |
| Q45364181 | Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment |
| Q85179316 | Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice |
| Q44396938 | Pathogenesis study of enterovirus 71 infection in rhesus monkeys |
| Q35132329 | Phenotypic and genotypic characteristics of novel mouse cell line (NIH/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv). |
| Q33942293 | Producing infectious enterovirus type 71 in a rapid strategy |
| Q38068107 | Progress on the research and development of human enterovirus 71 (EV71) vaccines |
| Q34921442 | Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice |
| Q35188294 | Proteomic analysis of human brain microvascular endothelial cells reveals differential protein expression in response to enterovirus 71 infection |
| Q64137476 | Pyroptosis induced by enterovirus A71 infection in cultured human neuroblastoma cells |
| Q37987923 | Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. |
| Q48065227 | Sequence analysis of six enterovirus 71 strains with different virulences in humans |
| Q36734771 | Strategies to develop antivirals against enterovirus 71 |
| Q35213105 | Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. |
| Q37401695 | Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds |
| Q34742485 | Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model |
| Q34046154 | The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses |
| Q28354106 | The Preferential Infection of Astrocytes by Enterovirus 71 Plays a Key Role in the Viral Neurogenic Pathogenesis |
| Q33732200 | The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments |
| Q42524022 | The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways |
| Q60917504 | Toll-Like Receptor 3 Is Involved in Detection of Enterovirus A71 Infection and Targeted by Viral 2A Protease |
| Q44444682 | Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice |
| Q37157420 | Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. |
| Q38192021 | Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine |
| Q40008921 | Viral protein synthesis is required for Enterovirus 71 to induce apoptosis in human glioblastoma cells |
| Q37801742 | Virology, epidemiology, pathogenesis, and control of enterovirus 71. |
Search more.